Signature Estate & Investment Advisors LLC Acquires 381 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Signature Estate & Investment Advisors LLC increased its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 4.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,282 shares of the financial services provider’s stock after acquiring an additional 381 shares during the period. Signature Estate & Investment Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,227,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in IBB. TIAA Trust National Association increased its position in iShares Biotechnology ETF by 33.2% during the fourth quarter. TIAA Trust National Association now owns 3,154 shares of the financial services provider’s stock valued at $417,000 after acquiring an additional 787 shares during the last quarter. FineMark National Bank & Trust bought a new position in iShares Biotechnology ETF during the 4th quarter valued at about $319,000. Modern Wealth Management LLC bought a new position in iShares Biotechnology ETF during the 4th quarter valued at about $237,000. Congress Wealth Management LLC DE raised its position in iShares Biotechnology ETF by 11.1% in the 4th quarter. Congress Wealth Management LLC DE now owns 2,416 shares of the financial services provider’s stock worth $319,000 after purchasing an additional 241 shares during the period. Finally, Runnymede Capital Advisors Inc. bought a new stake in iShares Biotechnology ETF in the fourth quarter worth about $233,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB opened at $132.97 on Wednesday. The firm has a market capitalization of $6.28 billion, a PE ratio of 27.83 and a beta of 0.84. The business has a 50 day simple moving average of $136.28 and a two-hundred day simple moving average of $139.16. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57.

iShares Biotechnology ETF Increases Dividend

The firm also recently disclosed a dividend, which was paid on Friday, March 21st. Shareholders of record on Tuesday, March 18th were given a $0.1212 dividend. The ex-dividend date was Tuesday, March 18th. This is an increase from iShares Biotechnology ETF’s previous dividend of $0.06.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.